Ocrelizumab-induced inflammatory bowel disease-like illness characterized by esophagitis and colitis

Medicine and Dentistry

• B Lymphocyte 33%
• Colitis 100%
• Colon 33%
• Depletion 33%
• Disease 100%
• Drug Megadose 33%
• Esophagitis 100%
• Esophagus 33%
• Female 33%
• Glucocorticoid 33%
• Multiple Sclerosis 33%
• Patient 33%
• Rituximab 33%
• Therapeutic Procedure 33%
• Venous Ulcer 33%

Immunology and Microbiology

• B Cell 33%
• Colon 33%
• Primary Progressive Multiple Sclerosis 33%